Who
Subbarao Uppaluri V
Director
Company insider
Files Form 4 as: Sr Vice President - CFO, Opko Health; Director, BioCardia; Director, Winston Pharmaceuticals; Director, Non Invasive Monitoring Systems Inc /fl/; Treasurer, Ideation Acquisition.
In numbers
- Trades disclosed
- 35
- Buys
- 9
- Sells
- 1
- Bought
- $459K
- Sold
- $0
- Companies
- 5
- Companies where not an officer
- 3
- First trade
- 3 May 2007
- Last trade
- 18 Jun 2026
- Last filed
- 22 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Jun 2026filed 22 Jun 2026 | OPK Opko Healthoption or derivative · Biotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 18 Jun 2026filed 22 Jun 2026 | OPK Opko Healthoption or derivative · Biotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 18 Mar 2026filed 20 Mar 2026 | OPK Opko Healthoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 18 Mar 2026filed 20 Mar 2026 | OPK Opko Healthoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 11 Aug 2016filed 12 Aug 2016 | BCDA BioCardiaBiotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 16 Jun 2011filed 17 Jun 2011 | OPK Opko HealthBiotechnology | SEC FORM 4 Bought | $3,4101,000 at $3.41 | filing |
| 19 May 2010filed 21 May 2010 | Winston Pharmaceuticalsoption or derivative | SEC FORM 4 Code S | —89,589 | filing |
| 19 May 2010filed 21 May 2010 | Winston Pharmaceuticals | SEC FORM 4 Sold | —209,449 | filing |
| 14 Apr 2010filed 15 Apr 2010 | OPK Opko Healthoption or derivative · Biotechnology | SEC FORM 4 Code A | —235,000 at $0.00 | filing |
| 8 Mar 2010filed 10 Mar 2010 | Non Invasive Monitoring Systems Inc /fl/option or derivative | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 25 Sep 2009filed 1 Oct 2009 | Winston Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —27,500 at $0.00 | filing |
| 24 Sep 2009filed 10 Mar 2010 | Winston Pharmaceuticalsoption or derivative | SEC FORM 4 Code C | —127 at $0.00 | filing |
| 24 Sep 2009filed 28 Sep 2009 | Winston Pharmaceuticalsoption or derivative | SEC FORM 4 Code C | —229 at $0.00 | filing |
| 24 Sep 2009filed 28 Sep 2009 | Winston Pharmaceuticalsoption or derivative | SEC FORM 4 Code C | —89,589 at $0.00 | filing |
| 24 Sep 2009filed 28 Sep 2009 | Winston Pharmaceuticalsoption or derivative | SEC FORM 4 Code C | —89.59 at $0.00 | filing |
| 24 Sep 2009filed 28 Sep 2009 | Winston Pharmaceuticals | SEC FORM 4 Code C | —127,000 | filing |
| 5 May 2009filed 6 May 2009 | OPK Opko Healthoption or derivative · Biotechnology | SEC FORM 4 Code A | —225,000 at $0.00 | filing |
| 23 Feb 2009filed 25 Feb 2009 | Non Invasive Monitoring Systems Inc /fl/option or derivative | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 6 Oct 2008filed 7 Oct 2008 | Ideation Acquisition | SEC FORM 4 Bought | $6,9001,000 at $6.90 | filing |
| 6 Oct 2008filed 7 Oct 2008 | Ideation Acquisition | SEC FORM 4 Bought | $6,7501,000 at $6.75 | filing |
News
Greenberg Traurig Advises OPKO Health on $722M+ Agreement to Sell Select BioReference Health Assets to LabcorpOPK · prnewswire.com · 21 Oct 2026Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference HealthOPK · prnewswire.com · 15 Oct 2026
0 headlines in the last 90 days name Subbarao Uppaluri V; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.